The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase 2 study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO) (OpACIN-neo).
 
Elisa A. Rozeman
No Relationships to Disclose
 
Alexander Christopher Jonathan Van Akkooi
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Emilie Routier
No Relationships to Disclose
 
Alexander M. Menzies
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Hanna Eriksson
No Relationships to Disclose
 
Myles Smith
No Relationships to Disclose
 
Richard A. Scolyer
No Relationships to Disclose
 
Christoph Hoeller
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Johan Hansson
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche
Travel, Accommodations, Expenses - Novartis
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Novartis; Roche
 
James M. G. Larkin
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Merck; Roche
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; MERCK; Novartis; Pierre Fabre; Roche/Genentech
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche/Genentech
 
Christian U. Blank
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche